CN Stock MarketDetailed Quotes

688658 Youcare Pharmaceutical Group

Watchlist
  • 17.17
  • +0.08+0.47%
Market Closed Apr 25 15:00 CST
7.73BMarket Cap62.44P/E (TTM)

Youcare Pharmaceutical Group Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Assets
Current assets
Money funds
-10.03%1.33B
8.98%1.55B
-3.79%1.51B
-1.88%1.73B
-10.67%1.48B
-17.72%1.42B
-17.60%1.57B
-19.45%1.77B
-31.98%1.66B
-22.64%1.73B
Transactional financial assets
--160.26M
--50M
----
----
----
----
----
----
----
25.00%100M
Notes receivable and accounts receivable
-28.08%716.13M
9.45%924.96M
-19.53%873.94M
-23.89%932.81M
-22.44%995.7M
-34.85%845.07M
26.20%1.09B
56.61%1.23B
48.20%1.28B
114.51%1.3B
-Notes receivable
2.45%104.43M
40.88%114.65M
95.34%118.78M
43.84%108.88M
82.24%101.94M
68.68%81.39M
24.90%60.81M
41.79%75.7M
13.05%55.94M
45.65%48.25M
-Accounts receivable
-31.56%611.7M
6.10%810.31M
-26.34%755.16M
-28.35%823.93M
-27.21%893.77M
-38.85%763.69M
26.28%1.03B
57.70%1.15B
50.32%1.23B
118.50%1.25B
Other receivables (including interest and dividends)
72.89%18.78M
-85.57%9.84M
-36.89%10.78M
-36.27%15.19M
-4.75%10.86M
209.39%68.2M
16.40%17.08M
52.16%23.83M
24.34%11.4M
44.37%22.04M
-Accrued interest receivable
----
----
-6.67%439.88K
----
----
-28.19%987.56K
-10.88%471.33K
----
----
-68.94%1.38M
-Other receivable
72.89%18.78M
----
-37.75%10.34M
----
-4.75%10.86M
----
17.42%16.61M
----
24.34%11.4M
----
Contractual assets
----
-58.59%395.98K
-54.34%450.44K
-78.41%321.51K
-76.41%337.19K
-70.93%956.35K
-68.12%986.59K
-72.29%1.49M
-72.73%1.43M
-52.96%3.29M
Advance payment
-27.83%52.67M
-22.09%52.31M
-25.88%37.76M
-6.37%49.7M
22.20%72.97M
3.96%67.15M
6.97%50.94M
33.24%53.09M
100.86%59.71M
183.08%64.59M
Inventories
4.07%757.34M
-0.46%749.35M
-0.00%764.14M
-10.21%745.06M
-1.44%727.69M
0.84%752.82M
-7.23%764.16M
10.89%829.78M
16.77%738.34M
35.17%746.55M
Receivable financing
-8.49%89.3M
-40.07%51.88M
-5.93%74.95M
-6.94%107.67M
21.15%97.58M
13.13%86.57M
134.24%79.68M
1,057.67%115.7M
45.15%80.55M
241.24%76.52M
Other current assets
-19.44%31.67M
-28.14%36.57M
58.32%47.16M
-42.35%42.72M
-43.16%39.31M
69.18%50.88M
-14.10%29.79M
105.11%74.1M
119.96%69.15M
31.41%30.08M
Total current assets
-7.79%3.16B
3.99%3.43B
-7.76%3.32B
-11.33%3.63B
-12.22%3.42B
-19.05%3.29B
-5.87%3.59B
6.77%4.09B
-4.04%3.9B
14.22%4.07B
Non Current assets
Other equity investment
0.00%500K
0.00%500K
0.00%500K
--500K
--500K
--500K
--500K
----
----
----
Other non-current financial assets
113.71%32.6M
58.50%25.25M
58.50%25.25M
1.69%15.25M
--15.25M
--15.93M
--15.93M
--15M
----
----
Fixed assets
-0.95%1.44B
----
27.75%1.47B
----
24.65%1.45B
----
-2.35%1.15B
----
-2.87%1.16B
----
Constru in process
14.62%539.86M
----
-17.68%475.95M
----
2.74%470.99M
----
219.46%578.17M
----
511.70%458.45M
----
Intangible assets
0.39%175.01M
-1.67%170.02M
-0.57%172.15M
-2.48%172.3M
-0.20%174.32M
-3.58%172.91M
-3.53%173.14M
-4.06%176.69M
-3.57%174.68M
34.16%179.33M
Development expenditure
9.66%285.7M
18.96%302.96M
21.55%278.09M
31.86%268.95M
34.24%260.53M
61.26%254.68M
53.70%228.78M
63.94%203.97M
101.82%194.08M
19.02%157.93M
Long deferred expense
-19.08%8.18M
3.10%8.74M
-13.08%9.83M
586.89%9.23M
1,129.81%10.11M
55.25%8.48M
163.45%11.3M
-71.53%1.34M
-51.85%822.43K
167.04%5.46M
Deferred tax assets
48.68%30.32M
1.92%19.23M
8.14%17.27M
3.24%19.03M
14.46%20.39M
-37.30%18.86M
-40.44%15.97M
-17.07%18.43M
44.33%17.82M
185.52%30.08M
Usufruct assets
-42.26%21.49M
-25.93%29.48M
-24.35%32.06M
-22.95%34.64M
-21.71%37.22M
-24.80%39.8M
-23.83%42.38M
-22.95%44.96M
70.94%47.54M
273.03%52.93M
Other non current assets
6.77%48.57M
-20.85%54.78M
-35.62%55.97M
-26.44%36.21M
-7.80%45.5M
-55.09%69.2M
-26.08%86.94M
-64.31%49.22M
-27.23%49.34M
268.12%154.09M
Total non current assets
3.76%2.58B
6.57%2.58B
10.15%2.54B
13.65%2.48B
17.99%2.49B
22.99%2.42B
21.73%2.31B
19.53%2.18B
26.88%2.11B
21.71%1.97B
Total assets
-2.93%5.74B
5.08%6B
-0.76%5.86B
-2.63%6.11B
-1.62%5.91B
-5.35%5.71B
3.29%5.9B
10.90%6.27B
4.92%6.01B
16.56%6.04B
Liabilities
Current liabilities
Short term loan
-67.89%112.97M
-45.59%202.72M
-17.79%310.77M
62.86%372.68M
54.05%351.77M
238.41%372.6M
--378M
--228.84M
2,434.19%228.35M
1,122.03%110.1M
Notes payable and accounts payable
-10.95%642M
-12.28%607.97M
-20.31%630.79M
-21.79%688.7M
-7.26%720.95M
-12.18%693.11M
3.79%791.56M
8.99%880.59M
-2.83%777.4M
16.32%789.28M
-Notes payable
-2.18%210.65M
-49.16%164.39M
-36.65%213.75M
-24.97%231.24M
-23.29%215.35M
-24.35%323.32M
-17.34%337.41M
-5.42%308.19M
-2.46%280.75M
64.42%427.39M
-Accounts payable
-14.69%431.34M
19.96%443.58M
-8.17%417.04M
-20.08%457.45M
1.80%505.6M
2.18%369.79M
28.13%454.16M
18.73%572.4M
-3.03%496.65M
-13.55%361.88M
Contract liabilities
50.07%44.54M
-11.52%23.93M
-41.73%23.65M
-18.21%37.49M
-48.01%29.68M
22.51%27.04M
72.34%40.59M
51.98%45.84M
92.01%57.09M
-14.50%22.07M
Salaries payable
6.75%55.08M
14.62%47.66M
17.30%44.53M
-0.15%46.4M
10.20%51.6M
1.79%41.58M
15.60%37.96M
43.27%46.47M
-9.17%46.82M
19.92%40.85M
Taxs payable
-65.41%24.97M
116.45%83.49M
-12.86%51.74M
5.97%58.06M
16.23%72.19M
-77.73%38.57M
-35.77%59.38M
-37.36%54.79M
-52.34%62.11M
113.50%173.21M
Other payable (including interest and dividends)
-36.40%559.33M
-3.08%744.56M
-8.97%727.53M
-0.49%799.29M
23.76%879.45M
3.58%768.2M
47.86%799.22M
52.97%803.25M
8.82%710.63M
54.05%741.65M
-Other payable
-36.40%559.33M
----
-8.97%727.53M
----
23.76%879.45M
----
47.86%799.22M
----
8.82%710.63M
----
Non current liabilities due within one year
124.05%60.9M
384.98%49.32M
207.45%30.76M
181.23%27.68M
180.72%27.18M
2.05%10.17M
1.62%10.01M
1.20%9.84M
103.06%9.68M
392.14%9.97M
Other current liabilities
50.56%5.73M
-11.21%3.06M
-45.05%2.86M
-17.20%4.84M
-47.68%3.81M
24.31%3.44M
76.04%5.2M
64.15%5.85M
91.39%7.27M
-5.79%2.77M
Total current liabilities
-29.54%1.51B
-9.82%1.76B
-14.10%1.82B
-1.94%2.04B
12.49%2.14B
3.43%1.95B
44.82%2.12B
38.70%2.08B
12.91%1.9B
43.70%1.89B
Current liabilities
Long term deferred income
24.89%116.21M
45.35%102.24M
48.14%104.32M
49.70%104.05M
28.66%93.05M
-9.83%70.34M
-20.07%70.42M
-27.72%69.51M
-22.82%72.32M
-12.54%78.01M
Lease liabilities
-50.78%14.46M
-33.88%21.19M
-30.84%23.96M
-28.26%26.69M
-26.03%29.38M
-27.74%32.05M
-26.13%34.64M
-24.70%37.2M
67.09%39.72M
257.34%44.35M
Total non current liabilities
265.89%647.64M
273.45%569.11M
330.02%451.77M
301.98%428.93M
57.98%177M
24.54%152.39M
-22.17%105.06M
-26.69%106.71M
-4.62%112.04M
13.44%122.37M
Total liabilities
-6.94%2.15B
10.66%2.33B
2.13%2.27B
12.92%2.46B
15.03%2.31B
4.71%2.11B
39.17%2.23B
32.90%2.18B
11.76%2.01B
41.41%2.01B
Shareholders equity
Paid-in capital
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
Capital reserve funds
0.00%2.65B
0.00%2.65B
0.00%2.65B
-1.68%2.65B
-1.35%2.65B
-2.34%2.65B
-1.57%2.65B
0.80%2.69B
1.37%2.68B
2.40%2.71B
Surplus reserve funds
18.94%192.92M
18.41%162.2M
18.41%162.2M
18.41%162.2M
18.39%162.2M
39.83%136.98M
39.83%136.98M
39.83%136.98M
39.86%137.01M
108.33%97.96M
Retained profit
1.06%389.55M
33.88%506.28M
-4.12%415.11M
-43.57%454.75M
-46.53%385.45M
-50.25%378.15M
-50.29%432.95M
1.49%805.86M
-1.34%720.85M
24.66%760.11M
Less:Treasury stock
81.90%100.02M
640.61%100.02M
--100.02M
--76.79M
--54.99M
--13.51M
----
----
----
----
Shareholders equity without minority interests
-0.28%3.58B
1.86%3.66B
-2.53%3.57B
-10.97%3.64B
-10.06%3.59B
-10.45%3.6B
-10.75%3.67B
1.80%4.08B
1.67%3.99B
7.06%4.02B
Minority interests
-25.21%7.33M
-12.44%8.27M
6.17%9.19M
11.72%9.62M
21.06%9.8M
27.71%9.45M
34.48%8.66M
91.20%8.61M
139.65%8.09M
91.40%7.4M
Total shareholder equity
-0.35%3.58B
1.82%3.67B
-2.51%3.58B
-10.92%3.64B
-10.00%3.6B
-10.38%3.61B
-10.67%3.67B
1.90%4.09B
1.79%4B
7.14%4.02B
Total liabilityies and equity
-2.93%5.74B
5.08%6B
-0.76%5.86B
-2.63%6.11B
-1.62%5.91B
-5.35%5.71B
3.29%5.9B
10.90%6.27B
4.92%6.01B
16.56%6.04B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
--
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Assets
Current assets
Money funds -10.03%1.33B8.98%1.55B-3.79%1.51B-1.88%1.73B-10.67%1.48B-17.72%1.42B-17.60%1.57B-19.45%1.77B-31.98%1.66B-22.64%1.73B
Transactional financial assets --160.26M--50M----------------------------25.00%100M
Notes receivable and accounts receivable -28.08%716.13M9.45%924.96M-19.53%873.94M-23.89%932.81M-22.44%995.7M-34.85%845.07M26.20%1.09B56.61%1.23B48.20%1.28B114.51%1.3B
-Notes receivable 2.45%104.43M40.88%114.65M95.34%118.78M43.84%108.88M82.24%101.94M68.68%81.39M24.90%60.81M41.79%75.7M13.05%55.94M45.65%48.25M
-Accounts receivable -31.56%611.7M6.10%810.31M-26.34%755.16M-28.35%823.93M-27.21%893.77M-38.85%763.69M26.28%1.03B57.70%1.15B50.32%1.23B118.50%1.25B
Other receivables (including interest and dividends) 72.89%18.78M-85.57%9.84M-36.89%10.78M-36.27%15.19M-4.75%10.86M209.39%68.2M16.40%17.08M52.16%23.83M24.34%11.4M44.37%22.04M
-Accrued interest receivable ---------6.67%439.88K---------28.19%987.56K-10.88%471.33K---------68.94%1.38M
-Other receivable 72.89%18.78M-----37.75%10.34M-----4.75%10.86M----17.42%16.61M----24.34%11.4M----
Contractual assets -----58.59%395.98K-54.34%450.44K-78.41%321.51K-76.41%337.19K-70.93%956.35K-68.12%986.59K-72.29%1.49M-72.73%1.43M-52.96%3.29M
Advance payment -27.83%52.67M-22.09%52.31M-25.88%37.76M-6.37%49.7M22.20%72.97M3.96%67.15M6.97%50.94M33.24%53.09M100.86%59.71M183.08%64.59M
Inventories 4.07%757.34M-0.46%749.35M-0.00%764.14M-10.21%745.06M-1.44%727.69M0.84%752.82M-7.23%764.16M10.89%829.78M16.77%738.34M35.17%746.55M
Receivable financing -8.49%89.3M-40.07%51.88M-5.93%74.95M-6.94%107.67M21.15%97.58M13.13%86.57M134.24%79.68M1,057.67%115.7M45.15%80.55M241.24%76.52M
Other current assets -19.44%31.67M-28.14%36.57M58.32%47.16M-42.35%42.72M-43.16%39.31M69.18%50.88M-14.10%29.79M105.11%74.1M119.96%69.15M31.41%30.08M
Total current assets -7.79%3.16B3.99%3.43B-7.76%3.32B-11.33%3.63B-12.22%3.42B-19.05%3.29B-5.87%3.59B6.77%4.09B-4.04%3.9B14.22%4.07B
Non Current assets
Other equity investment 0.00%500K0.00%500K0.00%500K--500K--500K--500K--500K------------
Other non-current financial assets 113.71%32.6M58.50%25.25M58.50%25.25M1.69%15.25M--15.25M--15.93M--15.93M--15M--------
Fixed assets -0.95%1.44B----27.75%1.47B----24.65%1.45B-----2.35%1.15B-----2.87%1.16B----
Constru in process 14.62%539.86M-----17.68%475.95M----2.74%470.99M----219.46%578.17M----511.70%458.45M----
Intangible assets 0.39%175.01M-1.67%170.02M-0.57%172.15M-2.48%172.3M-0.20%174.32M-3.58%172.91M-3.53%173.14M-4.06%176.69M-3.57%174.68M34.16%179.33M
Development expenditure 9.66%285.7M18.96%302.96M21.55%278.09M31.86%268.95M34.24%260.53M61.26%254.68M53.70%228.78M63.94%203.97M101.82%194.08M19.02%157.93M
Long deferred expense -19.08%8.18M3.10%8.74M-13.08%9.83M586.89%9.23M1,129.81%10.11M55.25%8.48M163.45%11.3M-71.53%1.34M-51.85%822.43K167.04%5.46M
Deferred tax assets 48.68%30.32M1.92%19.23M8.14%17.27M3.24%19.03M14.46%20.39M-37.30%18.86M-40.44%15.97M-17.07%18.43M44.33%17.82M185.52%30.08M
Usufruct assets -42.26%21.49M-25.93%29.48M-24.35%32.06M-22.95%34.64M-21.71%37.22M-24.80%39.8M-23.83%42.38M-22.95%44.96M70.94%47.54M273.03%52.93M
Other non current assets 6.77%48.57M-20.85%54.78M-35.62%55.97M-26.44%36.21M-7.80%45.5M-55.09%69.2M-26.08%86.94M-64.31%49.22M-27.23%49.34M268.12%154.09M
Total non current assets 3.76%2.58B6.57%2.58B10.15%2.54B13.65%2.48B17.99%2.49B22.99%2.42B21.73%2.31B19.53%2.18B26.88%2.11B21.71%1.97B
Total assets -2.93%5.74B5.08%6B-0.76%5.86B-2.63%6.11B-1.62%5.91B-5.35%5.71B3.29%5.9B10.90%6.27B4.92%6.01B16.56%6.04B
Liabilities
Current liabilities
Short term loan -67.89%112.97M-45.59%202.72M-17.79%310.77M62.86%372.68M54.05%351.77M238.41%372.6M--378M--228.84M2,434.19%228.35M1,122.03%110.1M
Notes payable and accounts payable -10.95%642M-12.28%607.97M-20.31%630.79M-21.79%688.7M-7.26%720.95M-12.18%693.11M3.79%791.56M8.99%880.59M-2.83%777.4M16.32%789.28M
-Notes payable -2.18%210.65M-49.16%164.39M-36.65%213.75M-24.97%231.24M-23.29%215.35M-24.35%323.32M-17.34%337.41M-5.42%308.19M-2.46%280.75M64.42%427.39M
-Accounts payable -14.69%431.34M19.96%443.58M-8.17%417.04M-20.08%457.45M1.80%505.6M2.18%369.79M28.13%454.16M18.73%572.4M-3.03%496.65M-13.55%361.88M
Contract liabilities 50.07%44.54M-11.52%23.93M-41.73%23.65M-18.21%37.49M-48.01%29.68M22.51%27.04M72.34%40.59M51.98%45.84M92.01%57.09M-14.50%22.07M
Salaries payable 6.75%55.08M14.62%47.66M17.30%44.53M-0.15%46.4M10.20%51.6M1.79%41.58M15.60%37.96M43.27%46.47M-9.17%46.82M19.92%40.85M
Taxs payable -65.41%24.97M116.45%83.49M-12.86%51.74M5.97%58.06M16.23%72.19M-77.73%38.57M-35.77%59.38M-37.36%54.79M-52.34%62.11M113.50%173.21M
Other payable (including interest and dividends) -36.40%559.33M-3.08%744.56M-8.97%727.53M-0.49%799.29M23.76%879.45M3.58%768.2M47.86%799.22M52.97%803.25M8.82%710.63M54.05%741.65M
-Other payable -36.40%559.33M-----8.97%727.53M----23.76%879.45M----47.86%799.22M----8.82%710.63M----
Non current liabilities due within one year 124.05%60.9M384.98%49.32M207.45%30.76M181.23%27.68M180.72%27.18M2.05%10.17M1.62%10.01M1.20%9.84M103.06%9.68M392.14%9.97M
Other current liabilities 50.56%5.73M-11.21%3.06M-45.05%2.86M-17.20%4.84M-47.68%3.81M24.31%3.44M76.04%5.2M64.15%5.85M91.39%7.27M-5.79%2.77M
Total current liabilities -29.54%1.51B-9.82%1.76B-14.10%1.82B-1.94%2.04B12.49%2.14B3.43%1.95B44.82%2.12B38.70%2.08B12.91%1.9B43.70%1.89B
Current liabilities
Long term deferred income 24.89%116.21M45.35%102.24M48.14%104.32M49.70%104.05M28.66%93.05M-9.83%70.34M-20.07%70.42M-27.72%69.51M-22.82%72.32M-12.54%78.01M
Lease liabilities -50.78%14.46M-33.88%21.19M-30.84%23.96M-28.26%26.69M-26.03%29.38M-27.74%32.05M-26.13%34.64M-24.70%37.2M67.09%39.72M257.34%44.35M
Total non current liabilities 265.89%647.64M273.45%569.11M330.02%451.77M301.98%428.93M57.98%177M24.54%152.39M-22.17%105.06M-26.69%106.71M-4.62%112.04M13.44%122.37M
Total liabilities -6.94%2.15B10.66%2.33B2.13%2.27B12.92%2.46B15.03%2.31B4.71%2.11B39.17%2.23B32.90%2.18B11.76%2.01B41.41%2.01B
Shareholders equity
Paid-in capital 0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M
Capital reserve funds 0.00%2.65B0.00%2.65B0.00%2.65B-1.68%2.65B-1.35%2.65B-2.34%2.65B-1.57%2.65B0.80%2.69B1.37%2.68B2.40%2.71B
Surplus reserve funds 18.94%192.92M18.41%162.2M18.41%162.2M18.41%162.2M18.39%162.2M39.83%136.98M39.83%136.98M39.83%136.98M39.86%137.01M108.33%97.96M
Retained profit 1.06%389.55M33.88%506.28M-4.12%415.11M-43.57%454.75M-46.53%385.45M-50.25%378.15M-50.29%432.95M1.49%805.86M-1.34%720.85M24.66%760.11M
Less:Treasury stock 81.90%100.02M640.61%100.02M--100.02M--76.79M--54.99M--13.51M----------------
Shareholders equity without minority interests -0.28%3.58B1.86%3.66B-2.53%3.57B-10.97%3.64B-10.06%3.59B-10.45%3.6B-10.75%3.67B1.80%4.08B1.67%3.99B7.06%4.02B
Minority interests -25.21%7.33M-12.44%8.27M6.17%9.19M11.72%9.62M21.06%9.8M27.71%9.45M34.48%8.66M91.20%8.61M139.65%8.09M91.40%7.4M
Total shareholder equity -0.35%3.58B1.82%3.67B-2.51%3.58B-10.92%3.64B-10.00%3.6B-10.38%3.61B-10.67%3.67B1.90%4.09B1.79%4B7.14%4.02B
Total liabilityies and equity -2.93%5.74B5.08%6B-0.76%5.86B-2.63%6.11B-1.62%5.91B-5.35%5.71B3.29%5.9B10.90%6.27B4.92%6.01B16.56%6.04B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --------Unqualified opinion------Unqualified opinion--
Auditor --------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More